How Much Does NAD+ Therapy Cost? A 2026 Price Breakdown

There's no published average price for NAD+ therapy — and printed numbers go stale fast. What matters is why prices differ by format and provider, plus a live comparison that stays current.

There's no published "average price" for NAD+ therapy anywhere — no government agency or medical institution tracks consumer pricing for a compounded wellness treatment the way they might for an FDA-approved drug. Pricing also changes frequently as providers adjust plans, so rather than quote numbers that go stale, this breaks down why prices vary as much as they do — with a live, current comparison linked at the end.

The Real Spread, and Why It Exists

NAD+ pricing varies meaningfully by provider and delivery format — commonly by roughly 2x between the lowest and highest options in the market. That's a big enough spread that it's worth understanding the actual drivers, not just shopping on price alone.

Why the Cheapest Option Might Not Be the Best One

Here's the detail worth knowing before assuming lower price means better value: the delivery format that tends to be priced lowest — nasal spray — is also the one with the least human evidence behind it. As we covered in detail in our NAD+ delivery format comparison, no published, peer-reviewed human clinical trial has directly measured intranasal NAD+'s systemic or brain-level absorption — and NAD+'s size and water solubility are exactly the molecular properties that research shows struggle to cross the nasal membrane efficiently.^[1]

That doesn't mean the nasal option doesn't work. It means the evidence gap between "cheapest" and "best-studied" is real here, and worth factoring into the decision alongside price.

Why Injectable Pricing Varies So Much on Its Own

Even setting the nasal spray aside, injectable NAD+ pricing spans widely across providers offering essentially the same delivery method. A few real factors drive this:

Dose and formulation differences.Providers don't always disclose exact dosing per unit price, which makes direct comparison harder than it looks — a lower monthly price isn't necessarily a lower cost-per-milligram if the dose or frequency differs.

Compounded sourcing differences. NAD+ is not FDA-approved for any therapeutic indication and is available almost exclusively as a compounded or supplement-category product.^[2] Compounding pharmacy relationships, ingredient sourcing, and formulation quality can all differ between providers even when the advertised product looks identical on paper.

Bundled vs. standalone pricing.Some providers price NAD+ as a standalone product; others build it into a broader membership or program fee. When comparing across providers, it's worth confirming whether the quoted price is genuinely the full cost, or whether there's a separate consultation or membership fee layered on top.

What Drives Cost Differences by Delivery Format Generally

Beyond NAD+ specifically, delivery format itself is a real cost driver across compounded treatments generally. IV infusion typically requires more clinical infrastructure (equipment, longer visit time, sometimes an in-person or nurse-administered component) than a self-administered injection or oral product, which is often reflected in price. Nasal and oral formats tend to be positioned as the "convenience" option — lower price, no needles, no infusion chair — which is part of why they're priced lower, independent of the evidence-quality gap discussed above.

The Bottom Line

There's no such thing as a single "market rate" for NAD+ therapy — pricing depends on provider, delivery format, and how the product is bundled or sold standalone. What matters more than any single number is understanding the tradeoffs: the cheapest option isn't necessarily the best-evidenced one, and comparing "price per month" across providers only makes sense once you know whether that number includes everything or just the medication itself.

For current, accurate pricing across every provider we track, see RENVA's live Longevity NAD+ comparison — pricing there updates directly from verified provider data, so it won't go stale the way a number printed in this article eventually would.